Difference of BNP in non-ST-segment elevation myocardial infarction and unstable angina in early differen-tial diagnosis and prognosis of risk assessment

VernacularTitle:B型钠尿肽在非ST段抬高性心肌梗死与不稳定性心绞痛中的早期鉴别诊断及预后危险分层评估
Author: Baoyang LIU ¹ ; Sumei WANG ; Fengmei ZHANG ; Shuye LIU
Author Information

1. 301800,天津医科大学宝坻临床学院
Keywords: non-ST elevation myocardial infrction; B-type natriuretic peptide; unstable angina
From: The Journal of Practical Medicine 2017;33(23):3956-3959
CountryChina
Language:Chinese
Abstract: Objective To evaluate the difference of B-type natriuretic peptide(BNP)levels between patients with Non-ST elevation myocardial infraction(NSTEMI)and those with unstable angina(UA)and to ex-plore its relationship with the risk factors of major adverse cardiovascular events(MACE)and its value in progno-sis. Methods BNP levels of 110 consecutive patients with NSTE-ACS including 60 cases of NSTEMI and 50 of UA were studied and the incidence of MACE within 6 months after discharge was followed. Results(1)BNP lev-els were higher in NSTEMI group than those in UA group.(2)There were 32 patients suffering from MACE during the following-up.BNP levels were significantly higher in patients with MACE.(3)The risk of suffering from MACE was greater in NSTEMI patients than that in UA patients. Conclusions The level of blood BNP can be used in the differential diagnosis between UA and NSTEMI.Meanwhile,it correlates with the clinical severity and outcome of NSTEMI and may potentially be used as a prognostic marker for NSTEMI.